Why the study?
Does surgical left cardiac sympathetic denervation prevent symptoms in young adults with catecholaminergic polymorphic ventricular tachycardia?
Does surgical left cardiac sympathetic denervation prevent symptoms in young adults with catecholaminergic polymorphic ventricular tachycardia?
Surgical left cardiac sympathetic denervation may be an effective long-term treatment for patients with catecholaminergic polymorphic ventricular tachycardia who remain symptomatic despite standard therapy.
May support left cardiac sympathetic denervation in refractory CPVT; leaves open need for prospective trials.
Catecholaminergic polymorphic ventricular tachycardia is a potentially lethal disease characterized by adrenergically mediated ventricular arrhythmias manifested especially in children and teenagers. Beta-blockers are the cornerstone of therapy, but some patients do not have a complete response to this therapy and receive an implantable cardioverter-defibrillator (ICD). Given the nature of catecholaminergic polymorphic ventricular tachycardia, ICD shocks may trigger new arrhythmias, leading to the administration of multiple shocks. We describe the long-term efficacy of surgical left cardiac sympathetic denervation in three young adults with catecholaminergic polymorphic ventricular tachycardia, all of whom had symptoms before the procedure and were symptom-free afterward.
No takes yet. Share an insight, caveat, or question.
Wilde et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: